Real-world evidence to inform real-world cancer care
Syapse partners with health systems, life sciences companies, and regulators to create a unified ecosystem and deliver clinical, programmatic, and valuable real-world data insights to advance precision medicine in the field of oncology.
Get the Right Therapy
Syapse helps health systems leverage real-world treatment trends, clinical characteristics, and outcomes to guide treatment decisions.
For Health Systems
Get the Therapy Right
Syapse helps life sciences companies by partnering to create high quality, fully integrated clinical genomic datasets that can be used to accelerate approvals.
For Life Sciences
Get the Evidence Right
Syapse helps regulators through collaboration, to apply our expertise to the shaping of regulatory standards for the creation of real-world evidence.
Learning Health NetworkWhat's new
Syapse Looks to Dive Deeper Into Large Health Systems for Data-Driven Cancer Insights
Fresh off a $68 million funding round, Syapse is moving quickly to expand its network of partnerships with life sciences companies, health systems, molecular laboratories, and regulators. “We’re right in the middle of growth mode right now,” CEO Ken Tarkoff said of the 13-year-old company. The San Francisco-based maker of software to support precision oncology care and drug discovery also raised $30 million in a round that closed in May 2020.
Read